Transparency of pharmaceutical clinical trial data: the position in Europe and the US
This article was originally published in SRA
Executive Summary
Ian Dodds-Smith and Jacqueline Mulryne examine the respective positions of the EU and the US on pharmaceutical clinical trial data transparency and tell companies how they can prepare for potential changes ahead.